{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:23:25Z","timestamp":1790396605223,"version":"4.1.0"},"reference-count":147,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Research Grants Council of Hong Kong Special Administrative Region","award":["T42-103\/16N"],"award-info":[{"award-number":["T42-103\/16N"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.jconrel.2018.08.023","type":"journal-article","created":{"date-parts":[[2018,8,12]],"date-time":"2018-08-12T10:12:12Z","timestamp":1534068732000},"page":"24-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"special_numbering":"C","title":["The molecularly imprinted polymer essentials: curation of anticancer, ophthalmic, and projected gene therapy drug delivery systems"],"prefix":"10.1016","volume":"287","author":[{"given":"Christian Antonio","family":"Tuwahatu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Chung","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Wah","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1432-9950","authenticated-orcid":false,"given":"Vellaisamy Arul Lenus","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2018.08.023_bb0005","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1021\/cr990099w","article-title":"Molecularly imprinted polymers and their use in biomimetic sensors","volume":"100","author":"Haupt","year":"2000","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0010","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00216-012-5840-y","article-title":"Protein-imprinted materials: rational design, application and challenges","volume":"403","author":"Yang","year":"2012","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1515\/acph-2017-0020","article-title":"Biomimetic insulin-imprinted polymer nanoparticles as a potential oral drug delivery system","volume":"67","author":"Treetong","year":"2017","journal-title":"Acta Pharma."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aca.2014.06.011","article-title":"Molecularly imprinted polymer based enantioselective sensing devices: a review","volume":"853","author":"Tiwari","year":"2015","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aca.2017.01.003","article-title":"Electrochemical sensors based on magnetic molecularly imprinted polymers: a review","volume":"960","author":"Y\u00e1\u00f1ez-Sede\u00f1o","year":"2017","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cej.2013.12.106","article-title":"Molecularly imprinted polymers as nicotine transdermal delivery systems","volume":"248","author":"Ruela","year":"2014","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.polymer.2016.08.074","article-title":"Synthesis and characterization of a novel magnetic molecularly imprinted polymer with incorporated graphene oxide for drug delivery","volume":"101","author":"Hemmati","year":"2016","journal-title":"Polymer (Guildf)."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0040","first-page":"226","article-title":"Synthesis, characterization and in vivo drug delivery study of a biodegradable nano-structured molecularly imprinted polymer based on cross-linker of fructose","volume":"97","author":"Asadi","year":"2016","journal-title":"Polym. (United Kingdom)."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0045","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.supflu.2006.01.013","article-title":"Supercritical fluid polymerisation and impregnation of molecularly imprinted polymers for drug delivery","volume":"39","author":"Duarte","year":"2006","journal-title":"J. Supercrit. Fluids"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2017.02.138","article-title":"Molecularly imprinted polymers based drug delivery devices: a way to application in modern pharmacotherapy. A review","author":"Luli\u0144ski","year":"2017","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0055","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.bios.2006.06.023","article-title":"Molecularly imprinted polymers for the recognition of proteins: the state of the art","volume":"22","author":"Bossi","year":"2007","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0060","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1021\/ac050802i","article-title":"Protein recognition via surface molecularly imprinted polymer nanowires","volume":"78","author":"Li","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0065","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.tibtech.2008.01.001","article-title":"Too large to fit? Recent developments in macromolecular imprinting","volume":"26","author":"Ge","year":"2008","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0070","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.actbio.2011.11.005","article-title":"Critical review and perspective of macromolecularly imprinted polymers","volume":"8","author":"Kryscio","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jchromb.2004.02.013","article-title":"Molecularly imprinted polymers: synthesis and characterisation","volume":"804","author":"Cormack","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0080","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1021\/acs.analchem.5b03804","article-title":"Applications of molecularly imprinted polymer nanoparticles and their advances toward industrial use: a review","volume":"88","author":"Wackerlig","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/cr980039a","article-title":"Enzyme-like catalysis by molecularly imprinted polymers","volume":"102","author":"Wulff","year":"2002","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0090","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.addr.2005.07.010","article-title":"Molecularly imprinted polymers: a bridge to advanced drug delivery","volume":"57","author":"Sellergren","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0095","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jchromb.2003.12.032","article-title":"Molecularly imprinted polymers for drug delivery","volume":"804","author":"Alvarez-Lorenzo","year":"2004","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0100","first-page":"1","article-title":"Molecular imprinted polymers as drug delivery vehicles","volume":"7544","author":"Zaidi","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.bios.2009.03.038","article-title":"Theoretical and computational strategies for rational molecularly imprinted polymer design","volume":"25","author":"Nicholls","year":"2009","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","article-title":"Challenges and strategies in anti-cancer nanomedicine development: an industry perspective","volume":"108","author":"Hare","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.addr.2012.09.038","article-title":"Cancer nanomedicines: so many papers and so few drugs!","volume":"65","author":"Venditto","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0120","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0125","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1039\/C6CS00061D","article-title":"Molecular imprinting: perspectives and applications","volume":"45","author":"Chen","year":"2016","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0130","first-page":"1","article-title":"Evolution of macromolecular complexity in drug delivery systems","volume":"1","author":"Kakkar","year":"2017","journal-title":"Nat. Publ. Gr."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0135","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.bbamem.2016.02.025","article-title":"Rational design of liposomal drug delivery systems, a review: combined experimental and computational studies of lipid membranes, liposomes and their PEGylation","volume":"1858","author":"Bunker","year":"2016","journal-title":"BBA - Biomembr."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2012.09.037","article-title":"Liposomal drug delivery systems: from concept to clinical applications","volume":"65","author":"Allen","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0145","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/cbdd.12085","article-title":"Antibody-Drug Conjugates for the Treatment of Cancer","author":"Flygare","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0150","doi-asserted-by":"crossref","DOI":"10.1039\/C3CS60273G","article-title":"Chemical modifications and bioconjugate reactions of nanomaterials for sensing, imaging, drug delivery and therapy","volume":"43","author":"Biju","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0155","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.1002\/adma.201200832","article-title":"Peptide targeted lipid nanoparticles for anticancer drug delivery","volume":"24","author":"Pearce","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0160","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1002\/anie.201307628","article-title":"Antibody \u2013 drug conjugates: an emerging concept in cancer therapy","volume":"53","author":"Chari","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejpb.2015.04.038","article-title":"Drug delivery's quest for polymers: where are the frontiers?","volume":"97","author":"Merkle","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0170","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cocis.2017.07.002","article-title":"Recent advances in oral delivery of macromolecular drugs and benefits of polymer conjugation","volume":"31","author":"Fuhrmann","year":"2017","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0175","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.cocis.2017.08.002","article-title":"A review on engineering polymer drug conjugates to improve combination chemotherapy","volume":"31","author":"Vogus","year":"2017","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0180","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1002\/anie.201700647","article-title":"Molecularly imprinted nanogels acquire stealth in situ by cloaking themselves with native dysopsonic proteins","volume":"56","author":"Takeuchi","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0185","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1039\/a902257k","article-title":"Chiral determination of various adrenergic drugs by thin-layer chromatography using molecularly imprinted chiral stationary phases prepared with \u03b1-agonists","volume":"124","author":"Suedee","year":"1999","journal-title":"Analyst"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0190","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jconrel.2008.05.001","article-title":"Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane","volume":"129","author":"Suedee","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0195","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ijpharm.2007.07.030","article-title":"S-Propranolol imprinted polymer nanoparticle-on-microsphere composite porous cellulose membrane for the enantioselectively controlled delivery of racemic propranolol","volume":"349","author":"Jantarat","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0200","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jconrel.2006.03.007","article-title":"Composite membrane of bacterially-derived cellulose and molecularly imprinted polymer for use as a transdermal enantioselective controlled-release system of racemic propranolol","volume":"113","author":"Bodhibukkana","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0205","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-3659(99)00261-8","article-title":"Evaluation of matrices containing molecularly imprinted polymers in the enantioselective-controlled delivery of \u03b2-blockers","volume":"66","author":"Suedee","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/app.41930","article-title":"The composite nanomaterials containing (R)-thalidomide-molecularly imprinted polymers as a recognition system for enantioselective-controlled release and targeted drug delivery","volume":"132","author":"Suksuwan","year":"2015","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0215","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/chir.530070109","article-title":"Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide","volume":"7","author":"Eriksson","year":"1995","journal-title":"Chirality"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0220","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s00280-011-1752-3","article-title":"miR-200bc\/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP","volume":"69","author":"Zhu","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0225","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12032-010-9797-4","article-title":"MiR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2","volume":"29","author":"Zhu","year":"2012","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.59566\/IJBS.2006.2085","article-title":"Chiral drugs: an overview","volume":"2","author":"Nguyen","year":"2006","journal-title":"Int. J. Biomed. Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0235","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jpba.2017.07.008","article-title":"The market of chiral drugs: chiral switches versus de novo enantiomerically pure compounds","volume":"147","author":"Calcaterra","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0240","series-title":"Specif. Drug Subst. Prod. Dev. Valid. Anal. Methods","first-page":"193","article-title":"Chiral methods","author":"He","year":"2013"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0245","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/jssc.201701191","article-title":"Development of a high-performance liquid chromatography method for the simultaneous determination of chiral impurities and assay of (S)-clopidogrel using a cellulose-based chiral stationary phase in methanol\/water mode","volume":"41","author":"Ferretti","year":"2018","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0250","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.chroma.2013.07.049","article-title":"A chiral high-performance liquid chromatography-tandem mass spectrometry method for the stereospecific analysis of enoyl-coenzyme A hydratases\/isomerases","volume":"1306","author":"Abdel-Mawgoud","year":"2013","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0255","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/bja\/88.4.563","article-title":"Chirality: a blueprint for the future","volume":"88","author":"Burke","year":"2002","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0260","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s12206-013-1141-4","article-title":"Analysis of bioheat transfer equation for hyperthermia cancer treatment","volume":"28","author":"Attar","year":"2014","journal-title":"J. Mech. Sci. Technol."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0265","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3109\/02656736.2015.1040471","article-title":"Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry","volume":"31","author":"Cihoric","year":"2015","journal-title":"Int. J. Hyperth."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0270","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.bmcl.2016.03.020","article-title":"Preparation and characterization of the pH and thermosensitive magnetic molecular imprinted nanoparticle polymer for the cancer drug delivery","volume":"26","author":"Kaamyabi","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0275","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.apsusc.2016.08.107","article-title":"A pH\/glutathione double responsive drug delivery system using molecular imprint technique for drug loading","volume":"389","author":"Zhang","year":"2016","journal-title":"Appl. Surf. Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0280","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/jps.23838","article-title":"Coordinate bonding strategy for molecularly imprinted hydrogels: toward pH-responsive doxorubicin delivery","volume":"103","author":"Zhang","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0285","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.biotechadv.2013.11.009","article-title":"PH-Sensitive nano-systems for drug delivery in cancer therapy","volume":"32","author":"Liu","year":"2014","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0290","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.msec.2016.01.059","article-title":"Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: characterization and cellular cytotoxicity","volume":"62","author":"Esfandyari-Manesh","year":"2016","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0295","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.carbpol.2015.09.006","article-title":"Tragacanth gum-based nanogel as a superparamagnetic molecularly imprinted polymer for quercetin recognition and controlled release","volume":"136","author":"Hemmati","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0300","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00253-003-1354-z","article-title":"Exudate gums: occurrence, production, and applications","volume":"63","author":"Verbeken","year":"2003","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0305","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/app.38931","article-title":"Polysaccharides derived from tragacanth as biocompatible polymers and Gels","volume":"129","author":"Fattahi","year":"2013","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2007.08.001","article-title":"Nanoparticles for drug delivery: the need for precision in reporting particle size parameters","volume":"69","author":"Gaumet","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0315","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1016\/j.biomaterials.2004.10.012","article-title":"Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications","volume":"26","author":"Gupta","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0320","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/asiamat.2010.6","article-title":"The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications","volume":"2","author":"Boyer","year":"2010","journal-title":"NPG Asia Mater."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0325","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/smll.200901403","article-title":"Rattle-type Fe3O4@SiO2 hollow mesoporous spheres as carriers for drug delivery","volume":"6","author":"Zhu","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0330","series-title":"Encyclopedia of Cancer","year":"2009"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0335","series-title":"Long-Circulating and Target-Specific Nanoparticles: Theory to Practice","first-page":"283","volume":"vol. 53","author":"Moghimi","year":"2001"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0340","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.addr.2012.04.010","article-title":"Nanoparticles in drug delivery: past, present and future","volume":"65","author":"Couvreur","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0345","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.molmed.2015.01.001","article-title":"Cancer nanomedicine: from targeted delivery to combination therapy","volume":"21","author":"Xu","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0350","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.7150\/thno.11544","article-title":"Magnetic nanoparticles in cancer theranostics","volume":"5","author":"Gobbo","year":"2015","journal-title":"Theranostics."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0355","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3109\/03639045.2014.948451","article-title":"Development of ocular drug delivery systems using molecularly imprinted soft contact lenses","volume":"41","author":"Tashakori-Sabzevar","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0360","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jconrel.2011.06.028","article-title":"Extended cyclosporine delivery by silicone-hydrogel contact lenses","volume":"154","author":"Peng","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0365","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.actbio.2010.10.003","article-title":"Supercritical fluid-assisted preparation of imprinted contact lenses for drug delivery","volume":"7","author":"Yanez","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0370","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.supflu.2010.02.007","article-title":"Anti-glaucoma drug-loaded contact lenses prepared using supercritical solvent impregnation","volume":"53","author":"Costa","year":"2010","journal-title":"J. Supercrit. Fluids"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0375","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0380","doi-asserted-by":"crossref","first-page":"683","DOI":"10.18433\/J3H60P","article-title":"Improvements in topical ocular drug delivery systems: hydrogels and contact lense","volume":"18","author":"Ribeiro","year":"2015","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0385","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1016\/j.biomaterials.2011.04.044","article-title":"Extended release of high molecular weight hydroxypropyl methylcellulose from molecularly imprinted, extended wear silicone hydrogel contact lenses","volume":"32","author":"White","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0390","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jbm.b.30613","article-title":"The elution of poly (vinyl alcohol) from a contact lens: the realization of a time release moisturizing agent\/artificial tear","volume":"80B","author":"Winterton","year":"2007","journal-title":"J. Biomed. Mater. Res. Part B Appl. Biomater."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0395","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1021\/nn5002968","article-title":"Diamond nanogel-embedded contact lenses mediate lysozyme-dependent therapeutic release","volume":"8","author":"Kim","year":"2014","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0400","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/35090602","article-title":"Catalysis by hen egg-white lysozyme proceeds via a covalent intermediate","volume":"412","author":"Vocadlo","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0405","first-page":"71","article-title":"Lysozyme","volume":"26","author":"Fleming","year":"1932","journal-title":"Proc. R. Soc. Med."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0410","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1755-3768.1987.tb08485.x","article-title":"The concentration of lysozyme and secretory IgA in tears from healthy persons with and without contact lens use","volume":"65","author":"Vinding","year":"1987","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0415","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1039\/c2tx20006f","article-title":"A comparative study of cellular uptake and cytotoxicity of multi-walled carbon nanotubes, graphene oxide, and nanodiamond","volume":"1","author":"Zhang","year":"2012","journal-title":"Toxicol. Res. (Camb)."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0420","doi-asserted-by":"crossref","first-page":"73ra21","DOI":"10.1126\/scitranslmed.3001713","article-title":"Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment","volume":"3","author":"Chow","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0425","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nnano.2011.209","article-title":"The properties and applications of nanodiamonds","volume":"7","author":"Mochalin","year":"2012","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0430","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nnano.2008.99","article-title":"Mass production and dynamic imaging of fluorescent nanodiamonds","volume":"3","author":"Chang","year":"2008","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0435","series-title":"Timoptic\u00ae (0.25% and 0.5% Timolol Maleate Ophthalmic Solution, NDA 18-086\/S-070, NDA 18-086\/S-072)","first-page":"1","author":"Merck & Co. Inc.","year":"1995"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0440","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejpb.2016.09.010","article-title":"Extended wear therapeutic contact lens fabricated from timolol imprinted carboxymethyl chitosan-g-hydroxy ethyl methacrylate-g-poly acrylamide as a onetime medication for glaucoma","volume":"109","author":"Anirudhan","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0445","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/app.34022","article-title":"Timolol-imprinted soft contact lenses: influence of the template: functional monomer ratio and the hydrogel thickness","volume":"122","author":"Yanez","year":"2011","journal-title":"J. Appl. Polym. Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0450","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/1567201811310030004","article-title":"Preparation of a molecularly imprinted soft contact lens as a new ocular drug delivery system for dorzolamide","volume":"10","author":"Malaekeh-Nikouei","year":"2013","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0455","series-title":"TRUSOPT\u00ae (dorzolamide hydrochloride ophthalmic solution), NDA 20\u2013408\/S-045","first-page":"3","author":"Merck & Co. Inc.","year":"2003"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0460","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1002\/jps.24537","article-title":"Imprinted contact lenses for sustained release of polymyxin B and related antimicrobial peptides","volume":"104","author":"Malakooti","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0465","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/OPX.0000000000000082","article-title":"Microbial analyses of contact lens--associated microbial keratitis","volume":"91","author":"Konda","year":"2014","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0470","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.biomaterials.2004.04.030","article-title":"Ocular release of timolol from molecularly imprinted soft contact lenses","volume":"26","author":"Hiratani","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0475","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jconrel.2011.09.087","article-title":"Sustained in vivo release from imprinted therapeutic contact lenses","volume":"157","author":"Tieppo","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0480","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1167\/iovs.14-14855","article-title":"In vitro and in vivo evaluation of novel ciprofloxacin-releasing silicone hydrogel contact lenses","volume":"55","author":"Hui","year":"2014","journal-title":"Investig. Opthalmology Vis. Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0485","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/ICL.0b013e318157e82a","article-title":"Contact lens safety and the FDA: 1976 to the present","volume":"33","author":"Saviola","year":"2007","journal-title":"Eye Contact Lens."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0490","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/mabi.200500065","article-title":"Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities","volume":"5","author":"Hiratani","year":"2005","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0495","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jconrel.2006.05.003","article-title":"Imprinted soft contact lenses as norfloxacin delivery systems","volume":"113","author":"Alvarez-Lorenzo","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0500","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nm.3793","article-title":"Therapeutic genome editing: prospects and challenges","volume":"21","author":"Cox","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0505","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature15818","article-title":"Gene therapy returns to centre stage","volume":"526","author":"Naldini","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0510","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nbt1117-998","article-title":"First AAV gene therapy poised for landmark approval","volume":"35","author":"Smalley","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0515","series-title":"LUXTURNA (voretigene neparvovec-rzyl) [package insert]","first-page":"1","author":"I. Spark Therapeutics","year":"2017"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0520","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000479157","article-title":"Subretinal injection: a review on the novel route of therapeutic delivery for vitreoretinal diseases","volume":"58","author":"Peng","year":"2017","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0525","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0927-7765(99)00079-X","article-title":"Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model","volume":"16","author":"Labhasetwar","year":"1999","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0530","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1021\/js980077+","article-title":"A DNA controlled-release coating for gene transfer: transfection in skeletal and cardiac muscle","volume":"87","author":"Labhasetwar","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0535","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/smll.201402933","article-title":"Effective gene delivery into human stem cells with a cell-targeting peptide-modified bioreducible polymer","volume":"11","author":"Beloor","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0540","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/gt.2008.185","article-title":"Intravenous transferrin, RGD peptide and dual-targeted nanoparticles enhance anti-VEGF intraceptor gene delivery to laser-induced CNV","volume":"16","author":"Singh","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0545","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/mt.2014.199","article-title":"AAV2 delivery of Flt23k intraceptors inhibits murine choroidal neovascularization","volume":"23","author":"Zhang","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0550","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1038\/sj.gt.3302579","article-title":"Dendrimer delivery of an anti-VEGF oligonucleotide into the eye: a long-term study into inhibition of laser-induced CNV, distribution, uptake and toxicity","volume":"12","author":"Marano","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0555","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijpharm.2004.03.013","article-title":"In vivo gene transfection via intravitreal injection of cationic liposome\/plasmid DNA complexes in rabbits","volume":"278","author":"Kawakami","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0560","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/anie.200503760","article-title":"Selective protein capture by epitope imprinting","volume":"45","author":"Nishino","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0565","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bios.2006.07.038","article-title":"The microcontact imprinting of proteins: the effect of cross-linking monomers for lysozyme, ribonuclease A and myoglobin","volume":"22","author":"Lin","year":"2006","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0570","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.bios.2006.06.035","article-title":"Using protein templates to direct the formation of thin-film polymer surfaces","volume":"22","author":"Rick","year":"2006","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0575","doi-asserted-by":"crossref","first-page":"20003","DOI":"10.1021\/am505551t","article-title":"Molecularly imprinted protein recognition cavities bearing exchangeable binding sites for postimprinting site-directed introduction of reporter molecules for readout of binding events","volume":"6","author":"Sunayama","year":"2014","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0580","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1016\/j.biomaterials.2006.03.020","article-title":"Detection of a specific DNA sequence by electrophoresis through a molecularly imprinted polymer","volume":"27","author":"Ogiso","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0585","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.bios.2004.06.027","article-title":"Imprinted polymer layer for recognizing double-stranded DNA","volume":"20","author":"Slinchenko","year":"2004","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0590","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1002\/elps.200600191","article-title":"Universal method for synthesis of artificial gel antibodies by the imprinting approach combined with a unique electrophoresis technique for detection of minute structureal differences of proteins, viruses and cells (bacteria). lb. Gel antibodies against p","volume":"28","author":"Takt\u0301sy","year":"2007","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0595","doi-asserted-by":"crossref","first-page":"6031","DOI":"10.1021\/nn401768s","article-title":"Sorting inactivated cells using cell-imprinted polymer thin films","volume":"7","author":"Ren","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0600","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1039\/C0CS00049C","article-title":"The rational development of molecularly imprinted polymer-based sensors for protein detection","volume":"40","author":"Whitcombe","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0605","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1021\/acsami.6b14340","article-title":"Programmed transfer of sequence information into a molecularly imprinted polymer for hexakis(2,2\u2032-bithien-5-yl) DNA analogue formation toward single-nucleotide-polymorphism detection","volume":"9","author":"Bartold","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0610","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1146\/annurev-pharmtox-010814-124844","article-title":"Therapeutic potential of t cell chimeric antigen receptors (CARs) in cancer treatment: counteracting off-tumor toxicities for safe car t cell therapy","volume":"56","author":"Gross","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0615","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nbt1017-891","article-title":"Epic $12 billion deal and FDA's approval raise CAR-T to new heights","volume":"35","author":"Dolgin","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0620","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/imr.12126","article-title":"CAR T cells: driving the road from the laboratory to the clinic","volume":"257","author":"Cheadle","year":"2014","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0625","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1200\/JCO.2017.35.15_suppl.3010","article-title":"First-in-human multicenter study of bb2121 anti-BCMA CAR T-cell therapy for relapsed\/refractory multiple myeloma: updated results","volume":"35","author":"Berdeja","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0630","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrd.2017.266","article-title":"The market for chimeric antigen receptor T cell therapies","volume":"17","author":"Yip","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/biot.201700095","article-title":"Bioengineering solutions for manufacturing challenges in CAR T cells","volume":"13","author":"Piscopo","year":"2018","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0640","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science (80-. )"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0645","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1038\/mt.2013.154","article-title":"Persistence and efficacy of second generation CAR T Cell against the LeY Antigen in acute myeloid leukemia","volume":"21","author":"Ritchie","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0650","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1158\/1078-0432.CCR-06-1183","article-title":"A phase I study on adoptive immunotherapy using gene-modified T cells for ovarian cancer","volume":"12","author":"Kershaw","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0655","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.semradonc.2004.04.008","article-title":"Tumor microenvironmental physiology and its implications for radiation oncology","volume":"14","author":"Vaupel","year":"2004","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0660","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/bjc.1991.326","article-title":"Are cancer cells acidic?","volume":"64","author":"Griffiths","year":"1991","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0665","first-page":"1","article-title":"Recognition, neutralization and clearance of target peptides in the blood stream of living mice by molecular imprinted polymer nanoparticles : a plastic antibody","author":"Hoshino","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0670","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.reactfunctpolym.2017.10.025","article-title":"Evaluation of molecularly imprinted polymer based on HER2 epitope for targeted drug delivery in ovarian cancer mouse model","volume":"121","author":"Hashemi-Moghaddam","year":"2017","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0675","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1039\/C6NR09449J","article-title":"Inducible epitope imprinting: \u201cGenerating\u201d the required binding site in membrane receptors for targeted drug delivery","volume":"9","author":"Liu","year":"2017","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0680","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/j.bios.2009.02.016","article-title":"Single chain fragment variable recombinant antibody functionalized gold nanoparticles for a highly sensitive colorimetric immunoassay","volume":"24","author":"Liu","year":"2009","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0685","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/protein\/3.8.703","article-title":"Site-specific attachment to recombinant antibodies via introduced surface cysteine residues","volume":"3","author":"Lyons","year":"1990","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0690","doi-asserted-by":"crossref","first-page":"30445","DOI":"10.1074\/jbc.M001672200","article-title":"Site-specific conjugation on serine \u2192 cysteine variant monoclonal antibodies","volume":"275","author":"Stimmel","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0695","first-page":"742","article-title":"Progress in nanomedicine: approved and investigational nanodrugs","volume":"42","author":"Ventola","year":"2017","journal-title":"P T."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0700","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1215\/18752160-2406053","article-title":"The reformulation regime in drug discovery: revisiting polyherbals and property rights in the ayurvedic industry","volume":"8","author":"Pordie","year":"2014","journal-title":"East Asian Sci. Technol. Soc."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0705","doi-asserted-by":"crossref","first-page":"1299833","DOI":"10.1080\/20016689.2017.1299833","article-title":"Filling the gap in CNS drug development: evaluation of the role of drug repurposing","volume":"5","author":"Caban","year":"2017","journal-title":"J. Mark. Access Heal. Policy."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0710","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nm.3596","article-title":"Overcoming drug development bottlenecks with repurposing: repurposing biguanides to target energy metabolism for cancer treatment","volume":"20","author":"Pollak","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0715","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/jmr.688","article-title":"Study on the recognition of templates and their analogues on molecularly imprinted polymer using computational and conformational analysis approaches","volume":"17","author":"Wu","year":"2004","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0720","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2005.07.016","article-title":"Controlled release of the herbicide simazine from computationally designed molecularly imprinted polymers","volume":"108","author":"Piletska","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0725","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.seppur.2006.06.023","article-title":"Effects of solvents on the adsorption selectivity of molecularly imprinted polymers: molecular simulation and experimental validation","volume":"53","author":"Dong","year":"2007","journal-title":"Sep. Purif. Technol."},{"key":"10.1016\/j.jconrel.2018.08.023_bb0730","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.aca.2005.11.068","article-title":"Computational design and synthesis of molecularly imprinted polymers with high binding capacity for pharmaceutical applications-model case: adsorbent for abacavir","volume":"559","author":"Chianella","year":"2006","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jconrel.2018.08.023_bb0735","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1158\/2159-8290.CD-16-1154","article-title":"Personalized in vitro and in vivo cancer models to guide precision medicine","volume":"7","author":"Pauli","year":"2017","journal-title":"Cancer Discov."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918304899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918304899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:34:28Z","timestamp":1759160068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918304899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":147,"alternative-id":["S0168365918304899"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.08.023","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The molecularly imprinted polymer essentials: curation of anticancer, ophthalmic, and projected gene therapy drug delivery systems","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}